A one-stop-shop CRO bringing together innovative platforms, strategic solutions and specialized expertise to drive drug development and advance diverse fields of research.
Policies, Terms & Conditions
Huningue, 14/02/2024 – Firalis Molecular Precision, today announced that it will be attending 18th annual BIO-Europe Spring taking place March 18–20, 2023 in Barcelona, Spain. The event is expected to bring together over 3,700 executives from biotech, pharma and finance companies to engage in 20,000+ one-to-one meetings.
BIO-Europe Spring is the place to meet the world under one roof and discover the latest innovations which will advance the medicines of tomorrow. EBD Group is committed to providing a forum for the global biopharma community to come together. That is why this year’s event will also feature three days of digital partnering in the week following the in-person event.
To schedule a meeting with Firalis Molecular Precision’s experts, register now at https://informaconnect.com/bioeurope-spring/
About BIO-Europe Spring
Over the years, BIO-Europe Spring has become Europe’s largest springtime partnering event. Its international reach makes it a one of a kind offering and gateway to the global life science community. The event will cater to the needs of the entire value chain, start-up and innovator educational programs, industry trends and outlooks from KOLs, company pitches, professional partnering meetings as well as various networking opportunities are part of the ROI proven feature set. BIO-Europe Spring is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Innovation Organization (BIO).
About Firalis Molecular Precision
Firalis Molecular Precision (FMP) is a fast-growing CRO & CDMO, providing advanced multi-omics solutions and tailored contract research services to the Life Sciences sector.
With headquarters in Huningue, France, and a presence in Cambridge, MA, USA, FMP is renowned for its commitment to innovation and excellence.
Leveraging cutting-edge technologies, FMP offers a comprehensive suite of bioanalytical services encompassing biobanking, multiomics-driven analyses (including genomics, proteomics, transcriptomics, lipidomics, and metabolomics), as well as omic data analysis, assay development, and custom in vitro diagnostic (IVD) kit manufacturing.
Our mission is to empower healthcare professionals, researchers, and biopharmaceutical entities with the tools and solutions they need to make progress towards better patient care and a more personalized medicine.
Share this article on your socials